Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis

Recently, a series of studies explored the correlation between the neutrophil to lymphocyte ratio and the prognosis of lung cancer. However, the current opinion regarding the prognostic role of the neutrophil to lymphocyte ratio in lung cancer is inconsistent. We performed a meta-analysis of publish...

Full description

Bibliographic Details
Main Authors: Yongmei Yin, Jun Wang, Xuedong Wang, Lan Gu, Hao Pei, Shougang Kuai, Yingying Zhang, Zhongbo Shang
Format: Article
Language:English
Published: Elsevier España 2015-07-01
Series:Clinics
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322015000700524&lng=en&tlng=en
_version_ 1811318907359723520
author Yongmei Yin
Jun Wang
Xuedong Wang
Lan Gu
Hao Pei
Shougang Kuai
Yingying Zhang
Zhongbo Shang
author_facet Yongmei Yin
Jun Wang
Xuedong Wang
Lan Gu
Hao Pei
Shougang Kuai
Yingying Zhang
Zhongbo Shang
author_sort Yongmei Yin
collection DOAJ
description Recently, a series of studies explored the correlation between the neutrophil to lymphocyte ratio and the prognosis of lung cancer. However, the current opinion regarding the prognostic role of the neutrophil to lymphocyte ratio in lung cancer is inconsistent. We performed a meta-analysis of published articles to investigate the prognostic value of the neutrophil to lymphocyte ratio in lung cancer. The hazard ratio (HR) and its 95% confidence interval (CI) were calculated. An elevated neutrophil to lymphocyte ratio predicted worse overall survival, with a pooled HR of 1.243 (95%CI: 1.106-1.397; Pheterogeneity=0.001) from multivariate studies and 1.867 (95%CI: 1.487-2.344; Pheterogeneity=0.047) from univariate studies. Subgroup analysis showed that a high neutrophil to lymphocyte ratio yielded worse overall survival in non-small cell lung cancer (NSCLC) (HR=1.192, 95%CI: 1.061-1.399; Pheterogeneity=0.003) as well as small cell lung cancer (SCLC) (HR=1.550, 95% CI: 1.156-2.077; Pheterogeneity=0.625) in multivariate studies. The synthesized evidence from this meta-analysis of published articles demonstrated that an elevated neutrophil to lymphocyte ratio was a predictor of poor overall survival in patients with lung cancer.
first_indexed 2024-04-13T12:33:24Z
format Article
id doaj.art-3403e8be433244f9bc6b8b5d34907e7b
institution Directory Open Access Journal
issn 1980-5322
language English
last_indexed 2024-04-13T12:33:24Z
publishDate 2015-07-01
publisher Elsevier España
record_format Article
series Clinics
spelling doaj.art-3403e8be433244f9bc6b8b5d34907e7b2022-12-22T02:46:44ZengElsevier EspañaClinics1980-53222015-07-0170752453010.6061/clinics/2015(07)10S1807-59322015000700524Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysisYongmei YinJun WangXuedong WangLan GuHao PeiShougang KuaiYingying ZhangZhongbo ShangRecently, a series of studies explored the correlation between the neutrophil to lymphocyte ratio and the prognosis of lung cancer. However, the current opinion regarding the prognostic role of the neutrophil to lymphocyte ratio in lung cancer is inconsistent. We performed a meta-analysis of published articles to investigate the prognostic value of the neutrophil to lymphocyte ratio in lung cancer. The hazard ratio (HR) and its 95% confidence interval (CI) were calculated. An elevated neutrophil to lymphocyte ratio predicted worse overall survival, with a pooled HR of 1.243 (95%CI: 1.106-1.397; Pheterogeneity=0.001) from multivariate studies and 1.867 (95%CI: 1.487-2.344; Pheterogeneity=0.047) from univariate studies. Subgroup analysis showed that a high neutrophil to lymphocyte ratio yielded worse overall survival in non-small cell lung cancer (NSCLC) (HR=1.192, 95%CI: 1.061-1.399; Pheterogeneity=0.003) as well as small cell lung cancer (SCLC) (HR=1.550, 95% CI: 1.156-2.077; Pheterogeneity=0.625) in multivariate studies. The synthesized evidence from this meta-analysis of published articles demonstrated that an elevated neutrophil to lymphocyte ratio was a predictor of poor overall survival in patients with lung cancer.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322015000700524&lng=en&tlng=enNLRLung CancerOverall SurvivalMeta-Analysis
spellingShingle Yongmei Yin
Jun Wang
Xuedong Wang
Lan Gu
Hao Pei
Shougang Kuai
Yingying Zhang
Zhongbo Shang
Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis
Clinics
NLR
Lung Cancer
Overall Survival
Meta-Analysis
title Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis
title_full Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis
title_fullStr Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis
title_full_unstemmed Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis
title_short Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis
title_sort prognostic value of the neutrophil to lymphocyte ratio in lung cancer a meta analysis
topic NLR
Lung Cancer
Overall Survival
Meta-Analysis
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322015000700524&lng=en&tlng=en
work_keys_str_mv AT yongmeiyin prognosticvalueoftheneutrophiltolymphocyteratioinlungcancerametaanalysis
AT junwang prognosticvalueoftheneutrophiltolymphocyteratioinlungcancerametaanalysis
AT xuedongwang prognosticvalueoftheneutrophiltolymphocyteratioinlungcancerametaanalysis
AT langu prognosticvalueoftheneutrophiltolymphocyteratioinlungcancerametaanalysis
AT haopei prognosticvalueoftheneutrophiltolymphocyteratioinlungcancerametaanalysis
AT shougangkuai prognosticvalueoftheneutrophiltolymphocyteratioinlungcancerametaanalysis
AT yingyingzhang prognosticvalueoftheneutrophiltolymphocyteratioinlungcancerametaanalysis
AT zhongboshang prognosticvalueoftheneutrophiltolymphocyteratioinlungcancerametaanalysis